SCREENING FDA-APPROVED COMPOUNDS IN A TREM2 CELL MODEL OF ALZHEIMER’S DISEASE: 2017 Abstract Supplement

Research output: Contribution to journalPoster abstractpeer-review

Original languageEnglish
Pages (from-to)P278
JournalAlzheimer's & Dementia
Volume13
Issue number7, Supplement
DOIs
Publication statusE-pub ahead of print - 20 Oct 2017

Cite this